about
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paragangliomaExome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaAnalysis of circulating microRNAs in adrenocortical tumorsAdjuvant mitotane treatment for adrenocortical carcinomaH-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.Seladin-1 expression is regulated by promoter methylation in adrenal cancerLow sensitivity of glucagon provocative testing for diagnosis of pheochromocytomaGuidelines for diagnosis and therapy of MEN type 1 and type 2.Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma.Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.Phaeochromocytoma.Clinical aspects of SDHx-related pheochromocytoma and paragangliomaAn immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.Genetics and biology of pheochromocytoma.Genetic screening for pheochromocytoma: should SDHC gene analysis be included?Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells.Incidental and metastatic adrenal masses.Xenograft models for preclinical drug testing: implications for adrenocortical cancer.Perioperative management of pheochromocytoma/paraganglioma: is there a state of the art?Diagnostic problems in pheochromocytoma.Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function.Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation.Rare diseases in clinical endocrinology: a taxonomic classification system.Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells.Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model.Human testicular secretion with increasing age.Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.Bilateral massive adrenal hemorrhage due to sepsis: report of two cases.Functional and in silico assessment of MAX variants of unknown significance.Klinefelter's syndrome: a study of its hormonal plasma pattern.Klinefelter's syndrome: effects of short-term testosterone administration on hypothalamic-pituitary axis function.DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.Gene expression profiling of benign and malignant pheochromocytoma.A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.
P50
Q26866944-988C91B9-5894-486E-B671-DCD49798524EQ28241168-FF3B0AE1-8485-47D8-9741-8B1178D9348BQ28303947-E2B3C434-8C1E-44E0-9F82-D41EAA6CCC04Q28305285-DA0F30EA-521C-4BBE-8C25-5FAF17A60AD2Q30789687-5F395126-F578-4CE0-82B0-020726E6FF5DQ33216796-82AC9DA1-DDD4-4EC7-94DE-0CD80199F3ABQ33577461-3BD10D8B-11C1-4591-9583-9AF8F976A441Q33586665-17C52158-09F0-4BE0-9BC1-C12411E46811Q34104591-CA2DF818-F365-4CEA-B6D4-19E1DFE5AEC3Q34276843-E156713A-D7CA-41E0-8FEF-EDEA9C6D3B2CQ34284740-81842F32-8A72-4700-9707-2929A08461AEQ34559805-8ADF0708-5E72-4B79-94BE-D1758712173FQ34947066-D810601A-346E-4B0A-871D-E632242D2DA5Q36236107-B10A831B-534A-484B-B636-215133AF0685Q36458394-221C1CAB-B563-4620-9C57-A27A63005EB1Q36477902-F04F07B6-CB94-4174-A74A-38E9B95D0282Q36629525-6B713C0D-F776-47D3-9E78-4AF6365518D0Q36788092-644C1938-ABC7-4F1E-8753-CAA5FC9AFD39Q37004602-1761C9A3-2A8F-4E34-ACA9-DFDA79DC8385Q37213634-5E21A784-036D-47FA-8EE7-84CDCF7EACFEQ37786919-77637514-564E-46E9-A6EB-3899A60A486CQ37822023-E354B5B5-B2BD-43BA-BDCD-08B78F8EAF58Q37953116-28D6B9FF-4697-4D9C-8D3B-909559500866Q38003946-16C912B1-28CE-4063-9DDD-F2DF117C7128Q38371835-40C4D4E1-285B-4081-AC94-8865FB160E0FQ38895328-102E945D-9F28-4E11-A935-20B5F7F56BC8Q39018519-0CAB4155-3CC6-4F6A-B758-E425C09D7B01Q39102141-D40E6A2D-74E2-409E-A746-C71A75A701ADQ39145703-0E983050-5E7C-421C-83D1-081541FB6D09Q39768197-F2B298A4-5C51-49C8-B7D4-12B5CC8D56D8Q39896885-5D26D0CC-8C16-40EE-ACC1-8AFD7F2464E2Q40483352-4C0644C7-0F24-477F-A381-483B9C44AE48Q40694890-4F05E938-7A7B-4675-A5D1-C50923F3D6A2Q40840010-FD9CDF89-D5F0-4D28-B781-B7AB4989E6F1Q41035541-9EC90FEA-6B4B-481E-B33B-F55BC6A2D52CQ41134442-E6F406C0-7E02-4176-A5A4-FBA4C5967A7CQ41137119-B548D75E-7FA2-4F97-943E-EFA054ED309EQ41336499-13C48940-DD55-4C9F-88A2-BFBB02514067Q41443242-2E0A3B9A-C886-40CF-9CEE-71056C1A553EQ42499435-21B1FE71-DEC3-43E7-B871-E49800F6AF3E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Mannelli
@ast
Massimo Mannelli
@en
Massimo Mannelli
@es
Massimo Mannelli
@nl
Massimo Mannelli
@sl
type
label
Massimo Mannelli
@ast
Massimo Mannelli
@en
Massimo Mannelli
@es
Massimo Mannelli
@nl
Massimo Mannelli
@sl
prefLabel
Massimo Mannelli
@ast
Massimo Mannelli
@en
Massimo Mannelli
@es
Massimo Mannelli
@nl
Massimo Mannelli
@sl
P106
P1153
7005177865
P21
P31
P496
0000-0002-8001-9857